Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.11 USD | +0.24% | -4.20% | -17.96% |
05-16 | Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $21 From $36, Maintains Overweight Rating | MT |
05-15 | Transcript : Abeona Therapeutics Inc., Q1 2024 Earnings Call, May 15, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.96% | 169M | |
+49.17% | 58.71B | |
-2.86% | 41.31B | |
+36.42% | 39.2B | |
-11.22% | 27.4B | |
+9.49% | 26.55B | |
-22.67% | 18.98B | |
+1.89% | 12.51B | |
+26.41% | 12.08B | |
+22.11% | 11.94B |
- Stock Market
- Equities
- ABEO Stock
- News Abeona Therapeutics Inc.
- Transcript : Abeona Therapeutics Inc., Q4 2020 Earnings Call, Mar 25, 2021